期刊文献+

质子泵抑制剂与小肠细菌过生长关系的研究 被引量:6

Relationship between the proton pump inhibitors and small intestinal bacterial overgrowth
下载PDF
导出
摘要 目的:探讨质子泵抑制剂(PPIs)的使用与小肠细菌过生长(SIBO)发生之间的关系。方法:采用前瞻性对照性研究收集30例服用低剂量PPI的患者、28例服用高剂量PPI的患者,20例健康志愿者作为对照,通过乳果糖呼气H2试验连续观察SIBO的发生情况。结果:低剂量PPI组中SIBO阳性18例,阴性12例,高剂量PPI组阳性22例,阴性6例,对照组阳性1例,阴性19例,低剂量与高剂量PPI组分别与健康对照组比较差异有统计学意义(P<0.01),高剂量PPI组与低剂量组比较差异有统计学意义(P<0.05);两个服药组的SIBO阳性率随服药时间的增加而增加(P>0.05);同一时间段,高剂量PPI组的SIBO阳性率高于低剂量PPI组(P>0.05);两组PPI的使用时间与SIBO阳性率均存在正相关。结论:长期、大量使用PPI的患者可增加小肠细菌过生长的阳性率,可能进一步增加疾病发生的风险。 Objective: To explore the relationship between the proton pump inhibitors(PPIs) and small intestinal bacterial overgrowth(SIBO). Methods: Thirty patients with low dose PPI, 28 patients with high dose PPI and 20 healthy volunteers were prospectively analysed by lactulose H2 breath test. Results: Eighteen SIBO positive and 12 negative cases in low dose PPI group, 22 SIBO positive and 6 negative cases in high dose PPI group, 1 SIBO positive and 19 negative cases in the volunteer group were observed. Significant difference was found between the two PPI groups and volunteer group(P〈0.01), as well as between the low dose PPI group and the high dose PPI group(P〈0.05);Longer duration of PPI therapy, there was accompanied by increased SIBO positive rate(P〉0.05); With the same duration of PPI use, the SIBO positive rate of high dose PPI group was significantly higher than low dose PPI group(P〉0.05); A positive relationship was found between the SIBO positive rate and the length of time taking PPI. Conclusion: High dose of PPI in the long term could increase the SIBO positive rate, which could induce some diseases.
作者 宋明伟 姜葵
出处 《天津医科大学学报》 2014年第6期445-447,458,共4页 Journal of Tianjin Medical University
关键词 质子泵抑制剂 乳果糖呼气H2试验 小肠细菌过生长 proton pump inhibitors lactulose H2 breath test small intestinal bacterial overgrowth
  • 相关文献

参考文献15

  • 1Williams C. Occurrence and significance of gastric colonization dur- ing acid-inhibitory therapy[J]. Best Pract Res Clin Gastroenterol, 2001, 15(3): 511.
  • 2Jacobs C, Coss Adame E, Attaluri A, et al. Dysmotility and proton pump inhibitor use are Independent risk factors for small intestinal bacterial and/or fungal overgrowth [J]. Aliment Pharmaeol Ther, 2013, 37(11): 1103.
  • 3Vakil N, van Zanten S V, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evi- dence-based consensus[J]. Am J Gastroenterol, 2006, 101(8): 1900.
  • 4杨雪敏,吕宗舜,王邦茂,戴鑫.小肠细菌过生长与非酒精性脂肪性肝病关系的探讨[J].天津医科大学学报,2013,19(3):223-225. 被引量:7
  • 5StotzerPO, KilanderAF. Comparison of the 1-gram (14)C-D-xy- lose breath test and the 50-gram Hydrogen glucose breath test for diagnosis of small intestinal bacterial overgrowth[J]. Digestion, 2000, 61(3): 165.
  • 6Ghoshal U C, Ghoshal U, Das K, et al. Utility of hydrogen breath tests in diagnosis of small intestinal bacterial overgrowth in malab- sorption syndrome and its relationship with oro-cecal Transit time [J]. Indian J Gastroenterol, 2006, 25(1): 6.
  • 7Law D, Pimentel M. Proton pump inhibitor therapy does not affect Hydrogen production on lactulose breath test in subjects with IBS[J]. Dig Dis Sci, 2010, 55(8): 2302.
  • 8Fried M, Siegrist H, Frei R, et al. Duodenal bacterial overgrowth during treatment in outpatients with omeprazole[J]. Gut, 1994, 35 (1): 23.
  • 9Nelis G F, Engelage A H, Samson G. Does long-term inhibition of gastric acid secretion with omeprazole lead to small intestinal bacte- rial overgrowth[J]. Neth J Med, 1994, 45(3): 93.
  • 10Riordan S M, Mciver C J, Duneombe V M, et al. Evaluation of the rice breath hydrogen test for small intestinal bacterial overgrowth[J]. Am J Gastroenterol, 2000, 95(10): 2858.

二级参考文献11

共引文献16

同被引文献52

  • 1Jan Bures,Jiri Cyrany,Darina Kohoutova,Miroslav Frstl,Stanislav Rejchrt,Jaroslav Kvetina,Viktor Vorisek,Marcela Kopacova.Small intestinal bacterial overgrowth syndrome[J].World Journal of Gastroenterology,2010,16(24):2978-2990. 被引量:53
  • 2白丽华,张萍,胡晓慧.医院感染与应用抑酸药相关性临床分析[J].中外医疗,2012,31(28):86-87. 被引量:2
  • 3孙宝君,李园,邹琳,俞森洋.老年社区获得性肺炎与胃食管反流[J].重庆医学,2005,34(7):1044-1045. 被引量:1
  • 4罗福如,刘福松,唐志斌,等.颅脑外伤重症监护患者合并肺部感染的危险因素分析[J].医药前沿,2013,9(16):185-185.
  • 5Marik PE.Aspiration pneumonitis and aspiration pneumonia[J].N Engl J Med,2001,344(9):665-671.
  • 6Luna CM,Blanzaco D,Niederman MS,et al.Resolution of ventilator associated pneumonia:prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome[J].Crit Care Med,2003,31(3):676-682.
  • 7Knaus WA,Draper EA,Wanger DP,et al.APACHEⅡ:a severity of classification system[J].Crit Care Med,1985,13(40):818-829.
  • 8Fagon JY,Chastre J,Hance AJ,et al.Nosocomial pneumonia in ventilated patients:a cohort study evaluating attributable mortality and hospital stay[J].Am J Med,1993,94(3):281-288.
  • 9Ott SR,Lode H.Diagnosis and therapy of aspiration pneumonia[J].Dtsch Med Wochenschr,2006,131(12):624-628.
  • 10Quagliarello V,Ginter S,Han L,et al.Modifiable risk factors for nursing home-acquired pneumonia[J].Clin Infect Dis,2005,40(1):1-6.

引证文献6

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部